A U.S. Food and Drug Administration panel has unanimously voted to reject an expanded indication for Parkinson's drug rasagiline (Azilect).

Acknowledging that early stage Alzheimer's disease patients often do not yet have symptoms, Mayo Clinic researchers have proposed adding two pre-clinical stages to better classify patients.

The overnight shift might seem like an easy way to make money, but a new study warns that disrupting your sleep cycle as a teen can increase your risk of developing multiple sclerosis.

Some forms of epilepsy are tough to treat with just a medication. A new study demonstrates that brain surgery is a viable alternative to medication therapies.

Iron is an essential element for a properly functioning body, but extemes of iron in the blood have different consequences. Strategies for optimizing iron levels are discussed in new research from the University of California - Los Angeles.

For middle-aged women with restless legs syndrome, it's not just itching and an irresistible urge to move the legs. It also may be a risk factor for high blood pressure.

The discovery of key brain receptors gives researchers new ammunition in finding new and innovative ways to treat Alzheimer's disease and disability from stroke.

For many Alzheimer's patients, the disease slowly erodes brain cognition. Others aren't so lucky and the decline can be rapid. The problem is there's been no way to identify those that quickly decline and need aggressive treatment.

The sooner you treat a disease like multiple sclerosis (MS), the better the outcome, right? Well, that statement appears to be somewhat true.

In a small preliminary study the drug gantenerumab appears to reduce amyloid levels in the brains of patients with Alzheimer's disease.